ATARA BIOTHERAPEUTICS INC (ATRA)

US0465131078 - Common Stock

0.6974  +0.04 (+5.51%)

After market: 0.7099 +0.01 (+1.79%)

Buy % Consensus

74

ChartMill assigns a Buy % Consensus number of 74% to ATRA. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 4.28. This target is 514.28% above the current price.
ATRA was analyzed by 13 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about ATRA.
In the previous month the buy percentage consensus was at a similar level.
ATRA was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 0.700.511.684.2813.65 - -27.59% 141.32% 514.28% 1,857.27%
Up and Down Grades
Date Firm Action Rating
2024-04-01 Stifel Maintains Hold -> Hold
2023-11-10 Goldman Sachs Maintains Sell -> Sell
2023-11-09 Mizuho Downgrade Buy -> Neutral
2023-11-09 Evercore ISI Group Downgrade Outperform -> In-Line
2023-11-09 HC Wainwright & Co. Downgrade Buy -> Neutral
2023-09-26 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-21 Citigroup Maintains Sell -> Sell
2023-08-09 EF Hutton Reiterate Buy -> Buy
2023-06-14 HC Wainwright & Co. Maintains Buy -> Buy
2023-05-09 Canaccord Genuity Maintains Buy
2023-02-09 EF Hutton Reiterate Buy
2023-02-09 HC Wainwright & Co. Maintains Buy
2023-02-07 Mizuho Reiterate Buy
2023-01-05 EF Hutton Initiate Buy
2022-08-16 Mizuho Maintains Buy
2022-08-09 Goldman Sachs Maintains Sell
2022-07-20 Citigroup Downgrade Neutral -> Sell
2022-07-13 Stifel Downgrade Buy -> Hold
2022-07-13 JP Morgan Downgrade Overweight -> Neutral
2022-05-24 Goldman Sachs Maintains Sell
2022-05-23 HC Wainwright & Co. Maintains Buy
2022-05-10 Citigroup Downgrade Buy -> Neutral
2022-01-03 JP Morgan Maintains Overweight
2021-05-13 JP Morgan Upgrade Neutral -> Overweight
2021-05-05 HC Wainwright & Co. Maintains Buy